ABOUT US > What's New
What's New
June
VHG Labs DBA LGC Standards (June 24, 2019)
Final Rule: Placement of Thiafentanil in Schedule II (June 18, 2019)
Importer of Controlled Substances Registration (June 17, 2019)
Interim Final Rule: Placement of Brexanolone in Schedule IV (June 17, 2019)
Interim Final Rule: Placement of Solriamfetol in Schedule IV (June 17, 2019)
Bulk Manufacturer of Controlled Substances Registration (June 13, 2019)
Sigma Aldrich Research (June 13, 2019)
Eli-Elsohly Laboratories (June 13, 2019)
Elizabeth C. Korcz, M.D.; Decision and Order (June 13, 2019)
Bulk Manufacturer of Controlled Substances Registration (June 6, 2019)
American Radiolabeled Chem (June 6, 2019)
SpecGx LLC (June 6, 2019)
Shertech Laboratories, LLC (June 6, 2019)
May
Importer of Controlled Substances Registration (May 22, 2019)
United States Pharmacopeial Convention (May 22, 2019)
30-Day Notice: Report of Mail Order Transactions (May 21, 2019)
Importer of Controlled Substances Registration (May 15, 2019)
Bulk Manufacturer of Controlled Substances Registration (May 15, 2019)
AMPAC Fine Chemicals Virginia, LLC (May 15, 2019)
Raquel Skidmore, M.D.; Decision and Order (May 15, 2019)
Fred J. Powell, M.D.; Decision and Order (May 15, 2019)
Rhodes Technologies (May 15, 2019)
Wildlife Laboratories, Inc. (May 15, 2019)
AndersonBrecon Inc. DBA PCI of Illinois (May 15, 2019)
S & B Pharma, Inc. (May 15, 2019)
AndersonBrecon, Inc. (May 15, 2019)
Final Rule: Placement of beta-Hydroxythiofentanyl in Schedule I (May 8, 2019)
Notice of Intent: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I (May 1, 2019)
April
Final Rule: Interlocutory Appeals in Administrative Hearings (April 30, 2019)
Palafox Pharmacy; Decision and Order (April 30, 2019)
Mylan Pharmaceuticals Inc. (April 30, 2019)
Chemical Names of Previously Controlled Fentanyl-Related Substances (April 19, 2019)
Temporary Order: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I (April 16, 2019)
Proposed Rule: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I (April 8, 2019)
Importer of Controlled Substances Registration (April 8, 2019)
Bulk Manufacturer of Controlled Substances Registration (April 8, 2019)
Synthcon, LLC (April 8, 2019)
Martin A. Barrios, M.D.; Decision and Order (April 8, 2019)
Craig M. Weingrow, M.D.; Decision and Order (April 8, 2019)
Richard Carter, M.D.; Decision and Order (April 8, 2019)
Sanyal Biotechnology, LLC (April 8, 2019)
SpecGx LLC (April 8, 2019)
Organic Standards Solutions International, LLC (April 8, 2019)
Unither Manufacturing LLC (April 8, 2019)
March
Siemens Healthcare Diagnostics Inc. (March 21, 2019)
Fisher Clinical Services, Inc. (March 21, 2019)
Joel A. Smithers, D.O.; Decision and Order (March 18, 2019)
William A. Sanpablo, M.D.; Decision and Order (March 18, 2019)
Sharp (Bethlehem), LLC (March 18, 2019)
Importer of Controlled Substances Registration (March 6, 2019)
Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)
Patheon Pharmaceuticals, Inc. (March 6, 2019)
S&B Pharma Inc. (March 6, 2019)
Siegfried USA, LLC (March 1, 2019)
Meridian Medical Technologies (March 1, 2019)
February
30-Day Notice: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488 (February 27, 2019)
Proposed Rule: New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222) (February 21, 2019)
Ajay S. Ahuja, M.D.; Decision and Order (February 21, 2019)
Importer of Controlled Substances Registration (February 21, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 21, 2019)
Johnson Matthey, Inc. (February 21, 2019)
Navinta LLC (February 21, 2019)
Noramco, Inc. (February 21, 2019)
Stepan Company (February 21, 2019)
Research Triangle Institute (February 21, 2019)
Curium US, LLC (February 20, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 11, 2019)
Robert T. Perez, M.D.; Decision and Order (February 11, 2019)
Miles J. Nelson, M.D.; Decision and Order (February 11, 2019)
Paul Surinder Singh, D.O.; Decision And Order (February 11, 2019)
PerkinElmer, Inc. (February 11, 2019)
Stepan Company (February 11, 2019)
Almac Clinical Services Incorp (ACSI) (February 11, 2019)
Importer of Controlled Substances Registration (February 7, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)
IsoSciences, LLC (February 7, 2019)
Kinetochem, LLC (February 7, 2019)
Johnson Matthey Pharmaceutical Materials, Inc. (February 7, 2019)
Research Triangle Institute (February 7, 2019)
Microgenics Corporation Thermo Fisher Scientific (February 7, 2019)
Chattem Chemicals (February 7, 2019)
Kurt L. Pflieger, M.D.; Order Dismissing Order To Show Cause (February 7, 2019)
Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as Schedule II Controlled Substances; Correction (February 7, 2019)
January 2019
Placement of MAB-CHMINACA in Schedule I (January 29, 2019)
